1. Use of Paliperidone Palmitate Throughout a Schizoaffective Disorder Patient's Gestation Period.
- Author
-
Zamora Rodríguez FJ, Benítez Vega C, Sánchez-Waisen Hernández MR, Guisado Macías JA, and Vaz Leal FJ
- Subjects
- Adult, Female, Humans, Pregnancy, Treatment Outcome, Antipsychotic Agents adverse effects, Paliperidone Palmitate adverse effects, Prenatal Exposure Delayed Effects chemically induced, Psychotic Disorders drug therapy
- Abstract
Introduction: Paliperidone palmitate treatment of schizophrenia or schizoaffective disorder is effective and well tolerated, but there is almost no data on its safety during pregnancy. Case report: An analysis is made of the safety and tolerability of paliperidone palmitate treatment throughout the gestation period in a 34-year-old patient diagnosed with schizoaffective disorder. Discussion: Paliperidone palmitate treatment throughout the gestation period was safe and well tolerated by both mother and foetus, there being no malformations or other perinatal complications in the newborn to date., (© Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2017
- Full Text
- View/download PDF